Results

1–10 of 20 results for model

Functional Assessment of a Novel 27-Gauge Multispot Laser Probe in a Surgical Simulation Eye Model
Kourous A. Rezaei, MD
Annual Meeting Talks
2025
Suprachoroidal Avoralstat, a Plasma Kallikrein Inhibitor, Stops Vascular Leakage in a Well-Established RabbitModel
Dilsher S. Dhoot, MD
Annual Meeting Talks
2025
North Carolina Macular Dystrophy NCMD-MCDR1- Analysis of Our Entire Database a Model Disease of Noncoding Mutations
Kent W. Small, MD
Annual Meeting Talks
2023
ApoE-Induced Tauopathy of the Retina As a Model of Neurodegeneration
Leo A. Kim, MD, PhD
Annual Meeting Talks
2023
Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Interplay of Retinal Ischemia and Choroidal Remodeling in Rhegmatogenous Retinal Detachment: Pathogenesis Insights and Pachychoroid Spectrum Implications
Eoi Jong Seo, MD, PhD
Annual Meeting Talks
2024
Inhibition of C1q Protects Photoreceptor Synapses in a Light Damage Model and Is a Potential Treatment for Geographic Atrophy
Patrick Dewey Williams, MD
Annual Meeting Talks
2022
Biodistribution of Suprachoroidal Drug and Viral Vector Delivery Across Animal Models and Human Trials
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2022
Modeling Zone as a Proxy for Absolute Avascular Retina Area and Retinopathy of Prematurity Risk
Darius M. Moshfeghi, MD, FASRS
Annual Meeting Talks
2022
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
On Demand Cases, Courses, and Papers
2021